AQR Capital Management - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,178,102
+23.1%
79,945
+0.5%
0.00%0.0%
Q2 2023$1,769,520
-3.1%
79,529
-5.6%
0.00%0.0%
Q1 2023$1,825,375
+27.0%
84,274
+19.1%
0.00%
+33.3%
Q4 2022$1,437,684
-23.2%
70,787
-3.0%
0.00%
-40.0%
Q3 2022$1,871,000
-13.7%
72,959
-20.0%
0.01%0.0%
Q2 2022$2,168,000
+15.4%
91,172
+9.3%
0.01%
+25.0%
Q1 2022$1,878,000
+26.3%
83,384
+11.0%
0.00%
+33.3%
Q4 2021$1,487,000
-19.7%
75,118
-20.2%
0.00%0.0%
Q3 2021$1,852,000
-13.2%
94,123
-3.0%
0.00%
-25.0%
Q2 2021$2,134,000
-13.0%
96,998
-5.9%
0.00%0.0%
Q1 2021$2,453,000
-35.2%
103,118
-28.7%
0.00%
-42.9%
Q4 2020$3,784,000
-18.8%
144,661
-46.0%
0.01%
-12.5%
Q3 2020$4,662,000
-13.5%
267,827
-16.4%
0.01%
-11.1%
Q2 2020$5,387,000
+49.7%
320,262
+5.8%
0.01%
+50.0%
Q1 2020$3,598,000
+139.7%
302,634
+144.0%
0.01%
+200.0%
Q4 2019$1,501,000
-47.4%
124,037
-38.5%
0.00%
-33.3%
Q3 2019$2,851,000
+27.2%
201,718
+0.3%
0.00%0.0%
Q2 2019$2,242,000
+23.9%
201,062
+30.4%
0.00%
+50.0%
Q1 2019$1,810,000
+10.4%
154,188
+25.7%
0.00%0.0%
Q4 2018$1,639,000
-51.0%
122,650
-48.6%
0.00%
-33.3%
Q3 2018$3,345,000
-40.8%
238,610
-33.7%
0.00%
-50.0%
Q2 2018$5,655,000
-1.1%
359,725
+3.4%
0.01%0.0%
Q1 2018$5,720,000
-55.5%
347,748
-51.1%
0.01%
-53.8%
Q4 2017$12,841,000
-28.8%
711,015
-23.9%
0.01%
-40.9%
Q3 2017$18,033,000
+135.3%
934,384
+43.8%
0.02%
+120.0%
Q2 2017$7,665,000
+94.5%
649,573
+80.6%
0.01%
+100.0%
Q1 2017$3,941,000
+281.5%
359,615
+152.7%
0.01%
+400.0%
Q4 2016$1,033,000
+32.4%
142,292
+18.6%
0.00%0.0%
Q3 2016$780,000
+47.4%
119,979
+23.9%
0.00%0.0%
Q2 2016$529,000
-43.7%
96,804
-51.8%
0.00%
-50.0%
Q1 2016$939,000
-35.2%
200,733
-31.0%
0.00%
-33.3%
Q4 2015$1,448,000
+132.1%
290,782
+75.2%
0.00%
+200.0%
Q3 2015$624,000
+87.4%
165,942
+199.1%
0.00%0.0%
Q2 2015$333,000
+41.1%
55,481
+31.5%
0.00%0.0%
Q1 2015$236,000
+26.2%
42,200
-32.4%
0.00%
Q4 2014$187,000
-18.0%
62,400
-26.8%
0.00%
-100.0%
Q3 2014$228,000
-4.6%
85,2000.0%0.00%0.0%
Q2 2014$239,000
-7.0%
85,200
+44.7%
0.00%0.0%
Q1 2014$257,00058,9000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,946,732$165,263,0007.72%
S&T BANK/PA 497,525$11,837,0001.93%
Parallel Advisors, LLC 1,563,974$37,207,0001.76%
Capital Impact Advisors, LLC 168,084$3,999,0001.40%
TANAKA CAPITAL MANAGEMENT INC 40,044$953,0001.21%
AJ WEALTH STRATEGIES, LLC 666,682$15,860,0001.13%
Bridge City Capital, LLC 110,512$2,629,0000.87%
Birchview Capital, LP 50,000$1,190,0000.71%
FAS Wealth Partners, Inc. 236,041$5,615,0000.58%
BURNEY CO/ 377,827$8,989,0000.44%
View complete list of CORCEPT THERAPEUTICS INC shareholders